Lidocaine/Tetracaine
利多卡因/丁卡因
Report date: 2026/02/14 13:58:45
Base Information
Drug NameLidocaine/Tetracaine
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2005/06/23
Country/Territory
CombinationsYes Tetracaine HydrochlorideLidocaine
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGalen Ltd
China Registration ClassN/A
Develop Information
Active CompaniesCantabria LabsCrescita Therapeutics IncGalderma Sa +[10]
Inactive CompaniesGalen SpecialtyUs Oncology Research LlcZars Pharma Inc
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A